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Objectives: Infertility is an important medical and social problem that has an impact on 
well-being. A significant development in the last 10 years in the study of human infertility has 
been the discovery that oxidative sperm DNA damage has a critical role in the etiology of poor 
semen quality and male infertility. Selenium (Se) is an essential element for normal testicular 
d  evelopment, spermatogenesis, and spermatozoa motility and function. The predominant 
biochemical action of Se in both humans and animals is to serve as an antioxidant via the 
Se-dependent enzyme glutathione peroxidase and thus protect cellular membranes and organelles 
from peroxidative damage. We explored the efficacy of Se in combination with vitamin E for 
improving semen parameters and pregnancy rates in infertile men.
Materials and methods: The study included 690 infertile men with idiopathic 
a  sthenoteratospermia who received supplemental daily Se (200 µg) in combination with vitamin 
E (400 units) for at least 100 days. The mean age of cases was 28.5 years (range 20–45), and 
the median age was 30 years. These cases had presented with male factor infertility (primary 
or secondary) for at least 1 year. The longest and shortest duration of infertility was 10 years 
and 1 year, respectively. The median time of diagnosis of infertility was 1 year with a mean 
of 2.5 years.
Results: We observed 52.6% (362 cases) total improvement in sperm motility, morphology, 
or both, and 10.8% (75 cases) spontaneous pregnancy in comparison with no treatment (95% 
confidence interval: 3.08 to 5.52). No response to treatment occurred in 253 cases (36.6%) after 
14 weeks of combination therapy. Mean difference between semen analyses of cases before and 
after treatment was 4.3% with a standard deviation of 4.29. On the basis of paired t-test results, 
combination therapy with oral Se and vitamin E was effective for treatment of asthenospermia 
or asthenoteratospermia or induction of spontaneous pregnancy (P # 0.001).
Conclusions: Supplemental Se and vitamin E may improve semen quality and have beneficial 
and protective effects, especially on sperm motility. We advocate their use for the treatment 
of idiopathic male infertility diagnosed with asthenoteratospermia or asthenospermia in semen 
analysis.
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Introduction
The World Health Organization (WHO) defines infertility as the inability of a couple 
to achieve conception or bring a pregnancy to term after 1 year or more of regular, 
unprotected sexual intercourse.1 Conception is normally achieved within 12 months in 
80%–85% of couples using no contraceptive measures. Although certain cases of male 
infertility are due to anatomical abnormalities, such as varicocele, ductal   obstructions, 
or ejaculatory disorders, an estimated 40%–90% of cases are due to deficient sperm International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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production of unidentifiable origin.2 Infertility is a major 
clinical concern, affecting 15% of all reproductive age 
couples. Male   factors, including decreased semen q  uality, 
are responsible for 25% of these cases.3,4   Currently, the 
etiology of suboptimal semen quality is poorly understood, 
and many   physiological, environmental, and genetic factors, 
including oxidative stress, have been   implicated.5 Selenium 
(Se) is important for reproductive functions such as testos-
terone metabolism and is a   constituent of sperm capsule 
s  elenoprotein. The administration of Se to subfertile patients 
induced a statistically significant rise in sperm motility.6 
Se is an essential trace element occurring in organic and 
inorganic forms. The organic form is found predominantly 
in grains, fish, meat, poultry, eggs, and dairy products 
and enters the food chain via plant consumption. Typical 
dietary intake of Se in the US is 80–120 µg/daily, and the 
recommended daily allowance is 70 µg in men and 50 µg 
in women.7 Selenoproteins participate in sperm structure 
integrity maintenance. Sperm capsular selenoprotein has an 
important structural role in spermatozoa in the form of glu-
tathione peroxidase   (GSH-Px).8 Increased reactive   oxygen 
species (ROS) decreases fertility because ROS attacks the 
membrane of the spermatozoa, decreasing their viability. 
Increasing Se encourages antioxidant GSH-Px activity, thus 
decreasing ROS and leading to increased male fertility.9,10 
Se could also protect against oxidative DNA damage in 
human sperm cells.
Vitamin E is one of the most important antioxidative 
m  olecules, residing mainly in the cell membranes. It is 
thought to interrupt reactions with lipid peroxidation and 
is a free radical scavenger generated during the univalent 
reduction of molecular oxygen and also normal   activity 
of oxidative enzymes.11 These radicals will lead to per-
oxidation of phospholipids in the mitochondria of the 
sperm and thus to their ultimate immotility.12 It is possible 
that vitamin E enhances the production of the scavenger 
  antioxidant enzymes.13
We studied the effect of daily oral supplementation of 
Se and vitamin E on the quality of semen parameters and 
pregnancy rate of couples with male factor infertility.
Materials and methods
subjects
From March 2007 to February 2010, 855 men with a mean 
age of 28.5 years (range 20–45 years) presenting with 
male factor infertility (primary or secondary) for at least 
1 year were screened for enrollment in this prospective 
single-arm study in one center. Any infertile male with 
asthenoteratospermia according to WHO guidelines was 
enrolled in our study. Any patient with teratospermia of 1% 
or 2% in combination with 10%–30% asthenospermia was 
enrolled in the study. There was no known medical condi-
tion that could account for infertility. Only patients seeking 
medical a  ttention for the disease were included in the study. 
The lo  west age was 20 years, the highest age 45 years, and 
the median 30 years. The longest duration of infertility 
was 10 years; the shortest duration was 1 year. The median 
time of diagnosis of i  nfertility was 1 year with a mean of 
2.5 years. A total of 752 cases (88%) had primary i  nfertility, 
and 103 cases (12%) suffered from secondary infertility 
(Table 1). Patients were included in the study after fulfill-
ing certain criteria, including a sperm count of .20 × 106/
mL, more than 1 year of failed attempt at conception, and 
no female factors.   Exclusion criteria were abnormal testes 
on physical examination, such as bilateral or unilateral 
testicular atrophy; reproductive hormone le  vels (  follicle 
stimulating hormone and luteinizing hormone) outside 
normal limits (increased or decreased in the case of primary 
testicular failure or secondary hypogonadotropic hypogo-
nadism, respectively); genital diseases, such as u  ndescended 
testes, varicocele; and history of genital surgery, oligo, or 
azoospermia. In the evaluation of cases, a history was taken, 
and on each patient we performed a p  hysical examination. 
All patients who met study inclusion and exclusion criteria 
provided informed consent before study entry, which was 
done in accordance with the Declaration of Helsinki.14 The 
Human Ethics C  ommittee approved the study protocol. 
Of the 985 screened patients, 855 cases met study inclusion 
and exclusion criteria and consented to proceed with the 
study protocol. The study consisted of a 14-week t  reatment 
phase. All patients were required to have ceased all medical 
therapy 6 weeks before study initiation. Eligible patients 
were assigned to fixed-dose treatment with 200 µg oral 
Se tablet (l-selenomethionine) daily in combination with 
400 IU synthetic vitamin E (α-tocopherol). Safety and 
tolerability of drugs were evaluated based on spontane-
ously reported adverse effects and physical examination 
Table 1 Demographic data
Total number of cases 855
Lost to follow-up cases 165
Final number of eligible cases 690
cases with primary infertility 752
cases with secondary infertility 103
Mean age and range (years) 28.5 and 20–45International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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during each patient visit. Patients were asked to report all 
treatment-emergent adverse events. Treatment-emergent 
adverse events were defined as any adverse event that first 
occurred or w  orsened after the treatment trial or during it. 
Patients voluntarily reported adverse events throughout 
the study.
semen collections
Semen was obtained from patients consulting the 
Highly Specialized Jihad Daneshgahi Infertility Center, 
Qom Branch (ACECR), which is affiliated to the Jihad 
  Daneshgahi Center in Tehran, Iran. This center is the only 
infertility center in the province. After liquefaction of 
the sample, the semen volume, sperm concentration, and 
morphology of sperm were determined using standard 
procedures.15 In each case, we did a semen analysis before 
treatment and another semen analysis at the end of 100 days 
of treatment. Before semen sample collections, patients 
were instructed to abstain from ejaculation for at least 48 h. 
  Instructions regarding proper semen   collection techniques 
were provided to patients at screening and throughout 
  treatment. All procedures and interpretations were in 
accordance with 1992 WHO criteria, and morphology was 
established according to the Kruger parameters. Samples 
were assessed at least twice for   volume, pH, sperm concen-
tration, progressive and total motility, and the percentage 
of normal forms. Two technicians were used. Standardized 
semen analysis techniques were taught to each technician at 
our infertility clinic. Normal WHO values included a sperm 
concentration of 20 × 106 spermatozoa/mL or greater and 
50% or greater motility with forward progression. Using 
Kruger strict criteria, males with .14% normal forms were 
considered normal. Semen classification was as   follows: 
normospermia was indicated by a sperm concentration 
of $20 × 106/mL, motility $50%, and $14% normal 
morphology; asthenospermia was indicated by a sperm 
concentration of $20 × 106/mL, ,50% motility, and normal 
morphology; and asthenoteratospermia was indicated by 
a sperm concentration of $20 × 106/mL, ,50% motility, 
and ,14% normal morphology.
statistical analysis
Statistical analysis was performed using SPSS software, 
Version 16 (SPSS Inc., Chicago, IL, USA). Values 
d  etermined before and after treatment were compared by the 
paired t-test. For all comparisons, P # 0.05 was considered 
significant.
Results
The primary endpoint was the proportion of patients who 
had a 5% or greater increase in improvement of motil-
ity or morphology or both from baseline following the 
14-week treatment period or impregnating their partner. 
A total of 165 patients withdrew from study prematurely 
after treatment initiation. The reasons for discontinuation 
were withdrawal of consent in 45, missing data in 37, and 
loss to follow-up in 83. All participants had abnormal 
sperm morphology using the Kruger strict criteria as well 
as asthenospermia. In 253 cases (36.6%), no difference 
in semen analysis occurred. Normal pregnancy occurred 
in 75 cases (10.8%). In 382 cases (55%), improvement 
in parameters of semen analysis occurred. Improvement 
in motility of at least 5% occurred in 144 cases (20.5%), 
motility improvement of more than 10% occurred in 155 
cases (22.5%), improvement in sperm morphology of at 
least 5% occurred in 21 cases (3%), and improvement in 
both morphology and motility occurred in 42 patients (6%) 
(Table 2). Mean difference between semen analyses of 
cases before treatment and after treatment was 4.3% with 
a standard deviation of 4.29.
Discussion
Se is an essential trace element for humans and animals.16 
Se is essential for sperm function and male fertility. Se defi-
ciency has been linked to reproductive problems in rats, mice, 
chickens, pigs, sheep, and cattle,17 and supplementation with 
Se has been reported to improve reproductive performance 
in sheep and mice.18 However, high Se intake has been asso-
ciated with impaired semen quality.19 This improvement is 
supplementation dependent, as all of the parameters returned 
to baseline values during the post-treatment period.20 Se 
is incorporated into enzymes that regulate normal body 
processes. One Se-dependent enzyme is GSH-Px. GSH-Px 
protects cellular membranes and lipid-containing organelles 
from peroxidative damage by inhibition and destruction 
of endogenous peroxides, acting in conjunction with vita-
min E to maintain integrity of these membranes. GSH-Px 
catalyzes the breakdown of hydrogen peroxide (H2O2) and 
certain organic   hydroperoxides produced by glutathione 
during the process of redox cycling. The toxicity of redox 
cycling c  ompounds is generally increased by Se deficiency, 
which results in nearly a twofold increase in glutathione-S-
transferase activity and glutathione synthesis in the liver. 
In order to protect human populations from excessive 
consumption of Se, 500 µg of Se was generally accepted as International Journal of General Medicine 2011:4
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the maximum acceptable daily intake. Therefore, it can be 
predicted that chronic selenosis occurs with a daily intake 
of ∼1000–1500 µg of elemental Se.21 Glutathione is vital to 
sperm antioxidant defenses and has demonstrated a positive 
effect on sperm motility.9 Se and glutathione are essential 
to the formation of phospholipid–hyperoxide GSH-Px, an 
enzyme present in spermatids that becomes a structural 
protein comprising over 50% of the mitochondrial capsule in 
the mid-piece of mature spermatozoa. Deficiencies of either 
substance can lead to instability of the mid-piece, resulting 
in defective motility.3
Vitamin E is a well-documented fat-soluble antioxidant 
and has been shown to inhibit free radical-induced damage 
to sensitive cell membranes.22 In one study, lipid peroxida-
tion in the seminal plasma and spermatozoa was estimated 
by malondialdehyde (MDA) concentrations. Oral supple-
mentation with vitamin E significantly decreased MDA 
concentration and improved sperm motility.13 The recom-
mended dietary allowance of vitamin E is 15 mg/day, and 
the tolerable upper intake level of any α-tocopherol form is 
1000 mg/day. Although in most healthy adults short-term 
supplementation with up to 1600 IU of vitamin E appears 
to be well tolerated and have minimal side effects, long-
term safety is questionable.23 Vitamins E and C also play 
critical roles as nonenzymatic antioxidants. Vitamin E plays 
a vital role in protecting cell membranes from oxidative 
  damage trapping and scavenging free radicals within cellular 
  membranes. Vitamin C is a water-soluble antioxidant that 
reduces radicals from a variety of sources and also serves to 
recycle oxidized vitamin E.
Suleiman et al13 investigated the effects of vitamin E on 
sperm motility. A total of 11 out of 52 treated patients (21%) 
impregnated their spouses, and improved motility of sperm 
was seen in 31 subjects.
Oxidative stress is induced by ROS or free radicals. 
Although ROS have been shown to be required for sperm 
capacitation, hyperactivation, and sperm–oocyte fusion,21 
excessive levels of ROS can negatively impact sperm quality. 
Increased levels of ROS have been correlated with decreased 
sperm motility,24 increased sperm DNA damage,25 sperm cel-
lular membrane lipid peroxidation,26 and decreased efficacy 
of oocyte–sperm fusion.27 The pathological effects of oxida-
tive stress arise under conditions in which levels of unscav-
enged ROS increase or the antioxidant buffering capacity of 
the system decreases, thus perturbing the delicate oxidant–
antioxidant balance. These free radicals induce sperm cell 
injury through several pathways and can significantly impact 
both sperm quality and function.27,28International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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In a systematic review of the effect of oral antioxidants 
(vitamins C and E, zinc, Se, carnitine) on male infertility 
by Ross et al29 17 randomized trials, including a total of 
1665 men, were identified. Of the 17 trials, 14(82%) showed 
an improvement in either sperm quality or pregnancy rate 
after antioxidant therapy.
In one study, 69 infertile Scottish men were given pla-
cebo, Se, or Se in combination with vitamins A, C, and E for 
3 months. At the end of the trial, both Se-treated groups had 
significant improvements in sperm motility; however, sperm 
density was unaffected. During the course of the study, 11% 
of the participants in the treatment groups impregnated their 
partner.30 This rate was similar in our study.
Hawkes et al19 investigated the effects of dietary Se on 
sperm motility in 11 cases of healthy men. Interestingly, they 
found that high Se diet (297 µg/day) could impair sperm 
motility. However, our prescribed dose was 200 µg/day, and 
our findings in a large series were the opposite.
Conclusion
After 14 weeks of treatment in 690 cases, mean motility 
increased significantly from baseline (P # 0.005) compared 
with that before the treatment period. A slight but statisti-
cally significant increase in the normal m  orphological sperm 
ratio from baseline was observed at the end of the 14-week 
period.
Based on our findings, medical therapy of asthenotera-
tospermia with oral antioxidants, such as a combination of 
Se and vitamin E, can improve quality of semen parameters 
or help in achieving normal pregnancy. The major limitation 
of our study is the lack of a placebo-controlled, double-blind 
design. However, more studies with a case control design 
are warranted.
Disclosure
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